MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    Clinical and Functional Outcomes of Antiviral and Immunomodulatory Therapies in Subacute Sclerosing Panencephalitis

    S. Errabelly, V. Jadhav, M. Tripathi, D. Dash, P. Mohapatra, E. Arunmozhimaran (New Delhi, India)

    Objective: To evaluate whether antiviral and immunomodulatory treatments meaningfully improve true functional status and disease stabilization, or if they merely prolong survival in a state…
  • 2026 International Congress

    Adult hippocampal neurogenesis and cognitive and neuropsychiatric symptoms in Parkinson’s disease: the MemHiN study

    L. Batzu, A. Podlewska, S. Farmand, F. Derbyshire-Fox, A. Woods, N. Crane, C. Pariante, S. Thuret (London, United Kingdom)

    Objective: To examine associations between serum-derived adult hippocampal neurogenesis (AHN)1 markers and cognitive and neuropsychiatric symptoms in Parkinson’s disease (PD), and to explore whether a…
  • 2026 International Congress

    Transcriptomic Profiling of Frataxin-Deficient Drosophila melanogaster to Identify Molecular Drivers and Pathway Disruptions in Friedreich’s Ataxia

    V. Swarup, R. Yadav, A. Ahuja, P. Yadav, A. Srivastava, D. Garg (New Delhi, India)

    Objective: To characterize the global transcriptomic changes and molecular pathways disrupted by frataxin deficiency in a Drosophila model of Friedreich's Ataxia (FA) to identify potential…
  • 2026 International Congress

    Psychosis in Parkinson’s Disease Patients Treated with Continuous Subcutaneous Foslevodopa/Foscarbidopa: A Real-World Observational Study.

    M. Angerri Nadal, C. Marzal Espi, R. Gomez Llopico, S. Jauma Classen, M. Calopa Garriga, H. Bejr-Kasem Marco (Barcelona, Spain)

    Objective: To assess the incidence and timing of psychosis (hallucinations and delusions) in Parkinson’s disease patients receiving continuous subcutaneous infusion of foslevodopa/foscarbidopa (CSFLI). Background: CSFLI…
  • 2026 International Congress

    Triplet repeat length determines the liquid-liquid phase separation propensity of single-dtranded DNA

    HJ. Yang, JI. Choi (Incheon, Republic of Korea)

    Objective: To determine whether CAG trinucleotide repeat number intrinsically governs liquid-liquid phase separation (LLPS) of single-stranded DNA (ssDNA). Background: LLPS has emerged as a fundamental…
  • 2026 International Congress

    Simulation Artifact in Complex Deep Brain Stimulation Patients

    A. Madamangalam, J. Tu, D. Vuddandam, J. Cagle, C. de Hemptinne, J. Wong (Gainesville, USA)

    Objective: To describe stimulation artifacts in patients with complex deep brain stimulation hardware configurations and the impact on electrophysiology recordings. Background: Deep brain stimulation (DBS)…
  • 2026 International Congress

    Low-dose ketamine reduces dopamine 2 receptor-like agonist-induced dyskinesia in a preclinical model

    T. Falk, R. Parmar, J. Meredith, J. Castro, E. Smith, M. Bartlett, S. Sherman (Tucson, USA)

    Objective: Preclinical evaluation of low-dose ketamine treatment on dyskinesia induced by direct or indirect striatofugal pathway activation. Background: Ketamine infusions are effective therapy for depression…
  • 2026 International Congress

    The Burden of Cognitive Impairment in People with Parkinson’s across Outpatients and Prevalent Patients in Coastal Kenya: A Transforming Parkinson’s Care in Africa (TraPCAf) Study

    R. Morton, S. Mwamba, D. Nyabuto, J. Nambafu, S. Kariuki, D. Sokhi, S. Ahmed, Y. Okkaoglu, C. Dotchin, C. Newton, N. Fothergill-Misbah, N. Okubadejo, R. Walker (Newcastle Upon Tyne, United Kingdom)

    Objective: To describe the rate and severity of cognitive impairment within the coastal Kenyan cohort of TraPCAf. Background: Cognitive impairment is a well-recognised non-motor symptom of PD, however there is very…
  • 2026 International Congress

    Self-Efficacy in Lewy Body Dementia Family Caregivers Is Associated with Better Sleep Quality and Social Support, and Lower Depression, Loneliness, and Strain

    M. Tharp, J. Hemm, S. Chen, V. Koliqi, E. Stevens, K. Fargo, R. Otto, D. Mariani, S. Seshadri, C. Bentley, T. Manak, A. Miller, C. Pensyl, C. Pierce, M. Voss, B. Ouyang, J. Chodosh, J. Fleisher (Chicago, USA)

    Objective: Examine the association of perceived self-efficacy in symptom management and community support service use with physical, psychological, and social well-being of Lewy Body Dementia…
  • 2026 International Congress

    Efficacy of Repetitive Transcranial Magnetic Stimulation for Improving Motor Function in Parkinson’s disease; A Prospective, Multicenter, Crossover Study

    SJ. Lee, HA. Kim, JE. Kim, MS. Shin, DY. Kown, HW. Shin (Seoul, Republic of Korea)

    Objective: We aimed to investigate the effect of repetitive transcranial magnetic stimulation (rTMS) on the improvement of motor function in patients with Parkinson’s disease (PD).…
  • « Previous Page
  • 1
  • …
  • 183
  • 184
  • 185
  • 186
  • 187
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley